Liposcience, previously backed by General Electric among others, is hoping for better results this time around, after an abortive float almost 10 years ago.
US-based medical diagnostics company LipoScience. previously backed by corporates including General Electric, plans to raise up to $86.3m in its initial public offering (IPO).
The filing contained no details concerning the number of shares due to be offered or the expected price, but it was confirmed that investment banks Barclays Capital, UBS Investment Bank and Piper Jaffray will underwrite the IPO. The company plans to list on Nasdaq.
LipoScience had previously filed for an IPO of up to…
